ID
25667
Description
Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Study conclusion.
Keywords
Versions (2)
- 8/25/17 8/25/17 -
- 9/8/17 9/8/17 -
Uploaded on
September 8, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727
Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727
Description
Pregnancy information
Description
Study conclusion
Description
Date
Data type
date
Alias
- UMLS CUI [1]
- C0011008 (Date in time)
- SNOMED
- 410671006
Description
Withdrawal
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,2]
- C1519255 (Serious Adverse Event)
Description
reason withdrawal
Data type
text
Alias
- UMLS CUI [1,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,2]
- C0392360 (Indication of (contextual qualifier))
- SNOMED
- 230165009
- LOINC
- MTHU008319
Description
other reason withdrawal
Data type
text
Alias
- UMLS CUI [1,1]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,2]
- C1519255 (Serious Adverse Event)
- UMLS CUI [1,3]
- C3840932 (Other Reason)
- LOINC
- LA6535-4
Description
Investigator comment log
Description
CRF page number
Data type
integer
Alias
- UMLS CUI [1,1]
- C0237753 (Numbers)
- SNOMED
- 260299005
- LOINC
- LP6841-3
- UMLS CUI [1,2]
- C1516308 (Case Report Form)
- UMLS CUI [1,3]
- C1515022 (Submission)
- LOINC
- LP91032-0
Description
Comment
Data type
text
Alias
- UMLS CUI [1]
- C0947611 (Comment)
- LOINC
- LP72293-1
Description
Investigator's signature
Description
Investigator Signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576 (Investigator Signature)
Description
signature date
Data type
date
Alias
- UMLS CUI [1]
- C0807937 (Signature date)
- LOINC
- MTHU008294
Description
Investigator name
Data type
text
Alias
- UMLS CUI [1]
- C2826892 (Investigator Name)
Similar models
Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727
C0678257 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C1519255 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C1519255 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,3])
C1516308 (UMLS CUI [1,2])
C1515022 (UMLS CUI [1,3])
No comments